 |
6 Diseases |  |
0 Trials |
|
0 Trials |  |
88 News |  |
| «12 |
- | theralizumab (TAB08) / TheraMab
New P1/2 trial, PK/PD data: Safety, Tolerability, Pharmacodynamics and Efficacy Study of TAB08 in Patients With Rheumatoid Arthritis (clinicaltrials.gov) - Nov 19, 2013
P1/2, N=18, Recruiting, Sponsor: Theramab LLC
- | theralizumab (TAB08) / TheraMab
Trial completion: Open Label Phase 1 Pharmacokinetics and Tolerability Study of Single TAB08 Administration in Healthy Volunteers (clinicaltrials.gov) - Sep 1, 2013
P1, N=31, Completed, Sponsor: Theramab LLC
Active, not recruiting --> Completed
- | theralizumab (TAB08) / TheraMab
New P1 trial: Open Label Phase 1 Pharmacokinetics and Tolerability Study of Single TAB08 Administration in Healthy Volunteers (clinicaltrials.gov) - Jun 23, 2013
P1, N=31, Completed, Sponsor: Theramab LLC